Evidence map›Paper›PMID 31062531›Full record

ArticleBrain tumor research and treatment2019

A Case of Recurrent Supratentorial Extraventricular Anaplastic Ependymoma in Adult.

Sung Won Seo, Ho Jun Kang, Min Seok Lee, Sang Jun Suh, Yoon Soo Lee, Jeong Ho Lee, Dong Gee Kang

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Brain tumor research and treatment, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sung Won SeoDepartment of Neurosurgery, Daegu Fatima Hospital, Daegu, Korea.
Ho Jun KangDepartment of Neurosurgery, Daegu Fatima Hospital, Daegu, Korea. nshojun@naver.com.
Min Seok LeeDepartment of Neurosurgery, Daegu Fatima Hospital, Daegu, Korea.
Sang Jun SuhDepartment of Neurosurgery, Daegu Fatima Hospital, Daegu, Korea.
Yoon Soo LeeDepartment of Neurosurgery, Daegu Fatima Hospital, Daegu, Korea.
Jeong Ho LeeDepartment of Neurosurgery, Daegu Fatima Hospital, Daegu, Korea.
Dong Gee KangDepartment of Neurosurgery, Daegu Fatima Hospital, Daegu, Korea.
Daegu Fatima Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Supratentorial extraventricular anaplastic ependymoma (SEAE) in adults is a relatively rare intracranial tumor. Because of the very low prevalence, only a few cases have been reported. According to a recent study, SEAE is associated with a poor prognosis and there is no definite consensus on optimal treatment. We report a case of an adult SEAE patient who had no recurrence until seven years after a gross total resection (GTR) followed by conventional radiotherapy. A 42-year-old male had a persistent mild headache, left facial palsy, dysarthria, and left hemiparesis. Preoperative neuroimaging revealed an anaplastic astrocytoma or supratentorial ependymoma in the right frontal lobe. A GTR was performed, followed by adjuvant radiotherapy. Histologic and immunohistochemical results revealed anaplastic ependymoma. After seven years of initial therapy, a regular follow-up MRI showed a 3-cm-sized partially cystic mass in the same area as the initial tumor. The patient underwent a craniotomy, and a GTR was performed. Histopathologic examination revealed recurrence of the SEAE. External radiotherapy was performed. The patient has been stable without any disease progression or complications for 12 months since the surgery for recurrent SEAE.

Indexed as

Anaplastic ependymomaRecurrenceSupratentorial neoplasms

Identifiers

PMID31062531
PMCPMC6504761
OpenAlexW2944059876

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.